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Abstract AIF4 activates heterotrimeric G-proteins Ga subunits 
but not small GDP/GTP-binding proteins like ARF1. On retinal 
membranes containing holotransducin (Gtacnp-Gd]3') and incu- 
bated with ARFGDp, AIF 4 induced Gt~GDP.AIF4 release and 
ARFGn P binding, probably to the remaining membrane-attached 
Gt~' y. On phospholipid vesicles reconstituted with Gt~'y, ARFGD P 
bound in proportion to Gt~/, and was released upon subsequent 
GtO~GD e addition. Thus ARFGD p competes with GtO~GD e for bind- 
ing to Gt/33,, probably through a conserved motif in the 'a2 helix' 
of Gt~ and ARE This motif is found in the C-terminal helix of 
PH domains that bind to Gi~v. 
Key words: ARF; G-protein; Gfl~'; Aluminofluoride; 
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1. Introduction 
ADP-ribosylation factors, or ARFs are a family of small (~ 20 
kDa) monomeric guanine-nucleotide binding proteins, origi- 
nally discovered as cofactors for cholera toxin-catalysed ADP- 
ribosylation of heterotrimeric G-protein G~ subunits [1]. But 
ARFs are localized at high concentration in the Golgi complex, 
and their main physiological function might be in vesicular 
transport [2]. ARF polypeptides are comparable in length and 
are weakly homologous to small G-proteins of the ras superfa- 
mily, but they display closer homologies with the guanine nu- 
cleotide binding domain of Gc~ subunits, taking into account 
that these Gc~ subunits have an additional a-helical domain 
distinct from the nucleotide binding domain [3,4]. Furthermore 
ARFs are acylated at the N-terminal, ike most Ga subunits, 
rather than isoprenylated at the C-terminal like ras. However, 
like ras, ARFs are not activated by aluminium fluoride [5], 
which activates the G~CDp subunit of heterotrimeric G-proteins 
by binding next to the fl phosphate of GDP, and simulating the 
y phosphate of GTP [6,7]. The observation that A1F~ could 
perturb the process of vesicle formation in the Golgi [8-11], 
thus led to speculations that an heterotrimeric G-protein might 
also be involved in the vesicular transport process in the Golgi. 
We have previously analysed the interaction of ARF with 
phospholipid membranes [12,13], using recombinant ARF pro- 
duced in E. coli and purified either in the unacylated form 
(rARF) or in the myristoylated form (myrARF). myrARFGD P
partially binds to phospholipid membranes, but rARFcD P re- 
mains fully in solution. Upon exchanging GDP for GTP),S, 
both rARFGvpr sand myrARF~Tpy s bind permanently to phos- 
pholipid membranes. As expected, A1F~ does not modify the 
binding of rARF~Dp or myr ARFcD P. 
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We have also analysed the interaction of heterotrimeric G-
proteins with phospholipid membranes, taking retinal 
transducin as model [14]. In the inactive GDP-bound state, 
transducin subunits are associated in GtC%Dp-Gd3y hetero- 
trimer and are membrane-bound; upon exchanging GDP for 
GTPT/S, the Gto~ subunit dissociates from Gtfly and is released 
from the membrane as soluble Gt~GTPyS; A1Fg induces also 
the dissociation of holotransducin a d the release of activated 
GtCtGDP_AlV4 leaving Gtf ly alone on the membrane. 
Here we investigated the interaction of ARF1 with 
transducin on unilluminated retinal rod membranes, which 
contain very little endogenous ARF and a large amount of 
transducin in the associated form Gt0~GDp-Gtfly. The mem- 
branes were incubated with exogenous rARF~D P. In the ab- 
sence of GTP, this added rARF~Dp bound only very weakly to 
the membrane. Treating these preparations with A1F4 had the 
expected effect of releasing soluble GtO~GDP.AIF4 from the mem- 
brane, but also the surprising effect of increasing the membrane 
binding of rARF. As this binding could not result from a direct 
action of A1F 4 on rARFGDp, we surmised that it revealed a
specific interaction of rARF~Dp with the Girly subunits that 
remained alone on the membrane. We inferred that in native 
membranes the rARF~Dp-GtflT/interaction washindered by the 
binding of Gt~GDP to Gtfl~'. This hypothesis was tested by 
studying the binding of ARF to phospholipid vesicles reconsti- 
tuted with various combinations of purified Gt~ and Girly 
subunits. 
2. Material and methods 
2.1. Buffers 
Isotonic buffer: 20 mM Tris-HC1, pH 7.5; 100 mM NaC1; 1.5 mM 
MgClz; 0.1 mM PMSF; 5 mMfl-mercapto-ethanol. For the experiments 
with Retinal Membranes, this buffer was complemented with 15/IM 
GDP. Low ionic strength buffer: 5 mM Tris-HC1, pH 7.5; 0.1 mM 
MgCI2; 0.1 mM PMSF; 5 mM fl-mercapto-ethanol. 
2.2. Phospholipid vesicles 
Large unilamellar vesicles were prepared as described by Szoka [15]. 
20 mg of azolectin (soybean lipids, Sigma) were dissolved in 6 ml of 
diethyl ether, 1 ml of aqueous buffer (50 mM HEPES, pH 7.5) was 
added, the mixture was sonicated 2 min at 0°C. The solvent was re- 
moved under educed pressure, the aqueous suspension fvesicles was 
filtered through 0.8/tm filter and stored at 4°C under argon. 
2.3. Bovine retinal rod outer segment membranes 
Bovine retinal rod outer segment membranes (ROS) were prepared 
under dim red light as described by Kiihn [16] and stored at -80°C. 
2.4. Proteins 
Non-myristoylated recombinant ARF1 (rARF) was expressed in
E. coli and purified near homogeneity b  a single anion exchange 
chromatography QAE Sepharose column (Pharmacia) s previously 
described [12]. 
Myristoylated recombinant ARF1 (myrARF) was obtained as 
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described elsewhere [13]. Briefly, bacteria were cotransformed with the 
pETlld/gly2ARF1 and pBB131/yeast N-myristoyl transferase plas- 
mids. After expression, cells were harvested and lysed. Myristoylated 
ARF was precipitated at35% saturation of ammonium sulfate whereas 
most bacterial proteins and the non-myristoylated form of ARF re- 
mained in the soluble fraction. Then sequential chromatography on
DEAE Sepharose and MonoS columns removed the remaining contam- 
inants and allowed to obtain myrARF near homogeneity. 
Transducin subunits Gt0~GDP, Gt~GTPF s and Gtfl ~ were extracted from 
ROS membranes and purified as previously described [14]. 
Quantitation of proteins binding to membranes orphospholipid ves- 
icles was made by densitometry of Coomassie blue stained SDS PAGE 
of aliquot pellet and supernatant fractions of the sedimented mem- 
branes. 
3. Results 
Recombinant unmyristoylated rARFaDp was added to na- 
tive, non illuminated retinal membranes, in which rhodopsin is 
inactive and transducin is in the basal Gt0~GDp-Gtfl )' state. The 
membranes were incubated in isotonic buffer (which retains 
transducin on the membrane), with 25 #M of rARF, a concen- 
tration in excess to that of transducin (10 #M) in the membrane 
suspension. After sedimentation, the proteins were extracted 
from the membrane pellet by low ionic strength washing, and 
were analysed by SDS PAGE. As observed previously with 
phospholipid vesicles [12], rARFaD P did not bind significantly 
to these retinal membranes: only a small proportion (~ 3%) of the 
total added rARF  was retained in the membrane pellet. An 
aliquot of the membrane suspension supplemented with rARF  
was treated with A1F4, in the dark, to activate transducin with- 
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Fig. 1. Increased binding of rARFaDp to retinal membranes upon the 
activation of endogenous transducin by A1F4. Retinal membranes (100 
pM rhodopsin, ~ 10#M transducin) suspended inisotonic saline buffer 
were incubated with 25 pM rARF; one aliquot was further incubated 
with A1F4 (50/.tM A1CI3, 5 mM NaF) and both samples were sedi- 
mented; a and b: SDS PAGE of soluble proteins in the supernatants 
of the untreated and A1F~ treated samples; c and d: proteins extracted 
by low ionic strength buffer from the corresponding membrane pellets. 
In (a) one recognises soluble retinal proteins (arrestin, phosducin, p26), 
small fractions of transducin Gt0~ and GtflT, and most of the added 
rARF that remained in solution (more than 90% of total, compare with 
c); the pellet (c) has retained most of the cGMP-phosphodiesterase 
(PDE) and of transducin, and a very small proportion of the added 
rARF. In (b), AIF] has significantly increased the solubility of Gt~ (and 
a little that of Gtflg); the major soluble pool of rARF does not seem 
significantly decreased, but in (d), correlated with the loss of Gt~ to the 
solution, one sees a 3-4-fold increase of the minor pool of rARF 
retained with the pellet. These data were reproduced over 5 independent 
experiments. 
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Fig. 2. Binding of rARFoD P to phospholipid vesicles reconstituted with 
Gtfl~' and Gt~ subunits. Suspensions of large unilamellar phospholipid 
vesicles (2 mg azolectin/ml) in saline buffer were supplemented with 
Gtfl Y (6 aM), Gt0~GD P (6 aM), Gt(~GTP7 s (5 aM) and A1F 4 (50 aM 
A1C13, 5 mM NaF) as indicated; rARFoD P was added to 5 pM final 
concentration. The vesicles were sedimented, and the protein content 
of supernatant (not shown) and pellet were analysed by SDS PAGE and 
densitometry of the Coomassie blue stained gels. In the absence of any 
transducin subunit (lanes 1 and 2), the vesicle-bound rARF amounts 
to only 3% of the total added. The addition of Gtfly induced amarked 
increase in rARF binding (lane 3), which was unsensitive to A1F2 (lane 
4). Further addition of Gt~GD P induced a decrease of rARF binding 
(lane 5), which was now sensitive to A1F4 (lane 6). Addition of G~GTPrS 
did not induce a decrease of the binding induced by Gtfl? (lane 7). These 
data were reproduced over 3 independent experiments. 
release in the supernatant of a large fraction of Gt0¢, in the 
Gt0~GDP_A1F4 form, and also the release of a small proportion of 
Gtfl ~ which is less tightly attached to membrane phospholipids 
when isolated than when associated with Gt0~GD a [14]. Thus, as 
expected, the pellet of the A1F4 treated sample retained much 
less Gt~ and a little less Gtfl ~" than the untreated control pellet. 
But, unexpectedly, this membrane pellet retained also much 
more rARF  than the control pellet, sedimented in the absence 
of A1F4 (Fig. 1). We have shown previously [12] that rARF  
binds to phospholipid membranes upon its activation by GTP 
or GTPTS, but it is well established [5], and we have also 
extensively checked (data not shown) that A1F~ does not acti- 
vate rARFGD P, and does not increase its binding to phospho- 
lipid vesicles. Thus the increased binding of rARF~Dp to the 
retinal membranes upon A1F4 treatment could not be due to an 
activation of rARFcD P by A1F4. We were compelled to assume 
an indirect effect of AIF4 through its action on another protein 
present on the retinal membrane, which would result in uncov- 
ering a site of interaction for ARFcDp. The most likely candi- 
date was the Gt~GD Psubunit of transducin, which is associated 
to Gtfly in the native membrane. Upon the activation by A1F4, 
Gt0~GDP.AIF4 dissociates from Gtfl ~' which remains membrane- 
bound and could provide a site of interaction for ARFGo P. 
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Fig. 3. Concentration dependence of Gtfl ~" and rARF~D Pbinding to 
phospholipid vesicles. Suspensions of phospholipid vesicles (5 mg azo- 
lectin/ml) in saline buffer were supplemented with 1 #M rARF~Dp 
and increasing concentrations of GtflY. After sedimentation, Tilt con- 
tent of pellet (e) and supernatant (©), and ARF content of pellet (~) 
were analyzed by SDS-PAGE and quantified by densitometry of
Coomassie blue stained gels. G~fly-vesicle binding is strictly linear with 
(G~fly) in this concentration range. ARF binding was modeled with a 
bimolecular interaction scheme assuming the same affinity for G,fl), in 
solution and vesicle-bound G,By. The best fit (thick line) was obtained 
for kd = 10 #M. 
To investigate this hypothesis we studied the binding of 
rARF to model phospholipid vesicles upplemented with puri- 
fied Gtfl ~' and/or Gtc~ subunits (Fig. 2). We used the same 
sedimentation assay as with retinal membranes. We had previ- 
ously documented the binding of transducin subunits added at 
micromolar concentrations to these phospholipid vesicles [14]: 
under our standard incubation and sedimentation conditions, 
native, isolated Gt~GD P subunits, as well as Gt(ZGTP). s and 
Gt0~GDP_AIF4 , bound only in a small proportion (~ 15%); native 
isolated Gtfly subunits bound more (~ 60% in the vesicle pellet); 
when both Gt~op and Gtfl~/were added together, they bound 
cooperatively asGt~op-GtflT/heterotrimers, 80% of both sub- 
units sedimenting in the vesicle pellet. In contrast Gt~GTPr s or 
GtC%DP-AIV4, when added together with Gtfl) t, remained mostly 
in solution and did not increase the binding of Gtfl)'. 
As observed previously [12], a very small proportion (~ 3%) of 
the rARF that was incubated with the phospholipid vesicle 
suspension sedimented with the vesicle pellet. An addition of 
pur i f ied Gt(ZGD P to the suspension did not induce any supple- 
mentary binding of rARF~D P to the vesicle pellet (not shown). 
By contrast, the addition to the suspension of purified Gtfl ~" 
increased the binding of rARF~D P to the pelleted vesicles by a 
factor of 3 to 4 (Fig. 2). As expected, this Gtfly-dependent 
binding of rARFaD P to the phospholipid vesicles was unsensi- 
tive to A1F4. 
The further addition of Gt~GDr', in stoichiometric amount to 
Gtfl)/, to the phospholipid vesicle suspension i cubated with 
rARF~Dp, induced the expected increase of Gtfl ~' binding to the 
vesicles, concurrent with a stoichiometric binding of Gtct, and 
induced also a very marked decrease of rARFGD P binding, 
down to the low level observed initially on the phospholipid 
vesicles before the addition of any of the transducin subunits. 
But now, an AIF4 treatment on these phosholipid vesicles up- 
plemented with rARFoDp and both Gt0~GD P and G~fly, had 
effects on Gt0~ and rARF binding: the pool of bound Gt0~ was 
substantially decreased, as expected from the solubilisation of
Gt0[GDP_AIF4 , and the binding of rARFrDp was increased up to 
the level that had been observed on vesicles upplemented with 
Gtfl2/alone: this duplicated exactly the observation made ini- 
tially on retinal membranes. As a control, an aliquot of the 
vesicle suspension i cubated with rARFGDp and Gtfly was sup- 
plemented with a stoichiometric amount ofGt~rprs. A fraction 
of this added Gt~GvPrs bound to the vesicles, but this did not 
increase the amount of bound Gtfl~' , nor decreased the binding 
of ARFoD P. Thus like Gt0~GDP_AIF4 , Gt0~GTP7 s did not interact 
with Gtfly on the membrane, and did not interfere with the 
binding of ARF~op to the membrane. All these observations 
concurred to suggest that rARF~Dp binds specifically to Gtfly 
on phospholipid vesicles, and that GtC~CD P inhibits this binding, 
probably by competing for a common site on Gtfl~'. 
Under all above conditions, that is with total concentrations 
of Otfl ~' and of rARFoD P in the micromolar range, this Gtfly 
dependent membrane binding of rARFoDp remained limited (of 
the order of I0% of the added rARFGDp), but it was propor- 
tional to the amount of vesicle-bound G~fly and to the concen- 
tration of rARFGo P in the suspension. This gave an upper limit 
of 3~50 #M for the affinity of rARFGD P for G,fly, under the 
simplistic assumption that GtflY would be totally membrane- 
bound, or that rARFGD e would bind exclusively to the mem- 
brane-bound Gtfly. But neither assumption is correct: a con- 
stant fraction (45%) of Tilt remained in solution, when Til T 
was added up to 20 ,uM in a 5 mg/ml phospholipid vesicle 
suspension (Fig. 3) and the fraction of vesicle-bound Tilt was 
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Fig. 4. Binding of myrARFoDp to phospholipid vesicles reconstituted 
with Gtct and G,fly subunits. Same conditions as in Fig. 2 except for 
the lower concentration (1 #M) of myrARF added here to the vesicle 
suspension. I  the absence of any transducin subunit ~30% of the total 
added myrARF was retained in the vesicle pellet (lane 1). The addition 
of GtflY induced a 10% increase in myrARF binding (lane 2).This is 
comparable tothe increase observed for rARF binding in Fig. 2, but 
is harder to see on the gel as the relative ffect is much smaller. Further 
additions of Gt0~ and AIF 4 have also effects comparable tothat seen on 
Fig. 2 with rARF. Addition of Gt~GDp alone (lane 7) had no effect on 
myrARFrDp binding. These data were reproduced over 3 independent 
experiments. 
M. Franco et al./FEBS Letters 362 (1995) 286-290 289 
A N-terminal domain 
I N-terminal helix ~~- '~L I -~ czl ~f 
*amphipathic helix* 
ARF myr-G N/FANL FKGL FGKKEMR I LMVG LDAAGKTT I LYK LK LG 4O 
0 OO000•  O00•OO O00 
@ta myr-GAGASAEEKHSRELEKKLKEDAEKDARTVKLLLLGAGESGKST IVKQMK I I 52 
~' " O0000000 OOO O0 O0 hydrophilic helix 
I~$ MTEYK LVVVGAGGVGKSALT I QL IQN 26 
Switch II domain 
F----M--~I-4"i =z ~-Ls~----~--~ 
ISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVV92 
0 • OOOOOO0 • • • O0  0 OO000 
LNFRMFDVGGQRSERKKWIHCFEGVTCIIFIA221 
0 O0000 0 O0 0 
CLLDILDTAGQEEYSAMRDQYMRTGEGFLCVF82 
B ARF (o2.) I RPL~RHY FQNT ARF (a2) I RPL.~RHY FQNT O0 IOI • 0 O0 • ~l  O000 
H-Ark (PH) LRKRpt~I HO.LKNV H-Lbc (PH) ERNS~I 0.1 I O.DT 
OOOleDO o • ERKK]mlHCFEGV Gta(=2) ERKIq~IHCFEGV Gt~(=2) oo led oo o
Fig. 5. (A) Sequence homologies between ARF, G~ and ras in the N-terminal nd 'Switch II' domains. (• = identity, © = analogy, secondary structure 
elements indexed as in [23]). The main site of interaction of G,~GDp with GtflT is in the N-terminal hydrophilic helix of G,~, which has no homology 
with the N-terminal mphipathic helix of ARF. The conserved leucins of the coiled-coil segment inGtc~ [21] are underlined. Another GDP-dependent 
site of interaction of Gtc~ with Gtfl~" is the 'ct2' helix of Gtct in the 'switch II' domain. This domain is better conserved inARF, which also binds Gtfl~,, 
than in ras which does not bind Gtfl 7. Thus the 'c~2' helix might be the site of interaction of ARFGD P with Gtfl)'. (B) Comparisons ofmotifs around 
the conserved tryptophan i  the 'ct2' helix of ARF and of G,~, and in the PH domain C-terminal helix of two PH domain proteins, quoted as such 
in [25,26]. 
not modified in the presence of ARF. This strongly suggests 
that ARF binds with the same affinity to soluble and to mem- 
brane-bound Tilt fractions. This is confirmed by the saturation 
of the concentration-dependent binding curve shown in Fig. 3, 
which was best fitted with the value of 10/,tM for the affinity 
of rARFGDp for Til T. 
The binding experiments on phospholipid vesicles were re- 
peated with recombinant myristoylated ARF (myrARFGop) in 
the incubation medium, instead of unacylated rARFGD P (Fig. 
4). But myrARFGD Pbinds already significantly tophospholipid 
vesicles [13]: under our standard conditions, in the absence of 
any transducin subunit, 30% of the added myrARFcD P sedi- 
mented with the phospholipid vesicle pellet. The addition of 
G~fl 7 induced an increment of binding of myrARFGD P to 
the pellet, that seemed smaller in relative term but was com- 
parable in absolute term to that observed under the same condi- 
tions with rARFGD P. This indicated that myristoylated ARFGD P 
has an affinity for GtflT that is comparable tothat of rARFGDP, 
but this affinity cannot be determined accurately by our mem- 
brane-binding assay, due to the large 'background' GtflT-inde- 
pendent binding. The specificity of this myrARFGoa-Gtfl T 
binding was demonstrated by the full reversion of the GtflT- 
dependent increment of myrARF binding to the vesicles upon 
the stoichiometric addition of Gt0~GD P (Fig. 4), and its regener- 
ation upon the further addition of AIF4, as in the case of 
rARF. 
Control experiments were also performed with ras. We used 
recombinant ras produced in E. coli [17], which is not farnesyl- 
ated and very soluble. RaSGD a did not bind to phospholipid 
vesicles, and additions of GtflT, or of Gt(ZGD P or of both sub- 
units did not induce any detectable binding (data not shown). 
4. Discussion 
Our reconstitution experiments demonstrate hat recombi- 
nant unmyristoylated rARF1 as well as myristoylated ARF1, 
in the inactive GDP-bound form, bind to Gtfl T subunits of 
transducin on phospholipid vesicles, but not to the Gt0~GD P-
Gtfl y heterotrimer. Indeed the addition of Gt~GDP inhibits 
ARFGD P binding to Gtfly, probably by competing for the same 
site on Gtfl T. By contrast Gt06GTPr s which does not bind to 
GtflT, does not inhibit the binding of ARF~Dp to GtflT. 
This accounts for the indirect action of AIF4 on ARF binding, 
that is observed only in the presence of both transducin sub- 
units: A1F4 increases ARFcDp binding to GtflT by converting 
Gt(ZGD P to Gt~GDP.AIF4 which loses its inhibitory effect on 
ARF~Dp binding to GtflT. The apparent binding affinity of 
rARFGD P for GtflT is of l0 #M and is not dependent on the 
membrane binding of GtflT. myrARFGDP binds more to the 
phospholipid membrane, but its affinity for GtflT is comparable 
to that of rARFGD P. Therefore, neither the myristyl of ARF, 
nor the farnesyl of Gtfly seem to contribute to the protein- 
protein interaction between ARF and Gtfl T. 
A major site of interaction of the G~ subunit of an hetero- 
trimeric G-protein with Gil T seems to be in the N-terminal helix 
of Gcz [18-21]. The myristyl at the N-terminal end of the helix 
contributes to the GCtGDp-GflT association [14] and it has been 
suggested on the basis of modeling [21], that a motif that in- 
cludes two highly conserved Leucin residues near the other end 
of this helix, is involved in a coiled-coil association with the 
Gil T subunit (see Fig. 5). The whole helix, which is very hydro- 
philic, is not visible in the cristallographic structure, which 
suggests that it is disordered and points away from the globular 
nucleotide-binding domain [22,23]. This makes it unlikely that 
the conformation ofthis N-terminal segment would be sensitive 
to GDP/GTP exchange in the nucleotide site. 
The N-terminal helix of ARF1 has no sequence homology, 
and most probably no structural nalogies with that of Gt~. In 
the recent crystallographic structure of ARFGD P [24], this am- 
phipathic N-terminal helix is seen to fold back in the globular 
structure of the GDP binding domain, and to make tight hydro- 
phobic contacts with other structural elements. There is there- 
fore no indication that the N-terminal helix of ARFGD P would 
play the same role as the N-terminal helix of Gt~ and contribute 
to ARFGDp binding to GtflT. Furthermore, this binding was 
observed as well in the absence of the myristyl, with rARF, as 
in its presence, with myrARF. 
Conklin and Bourne [4] have suggested that another or-helical 
segment on the effector binding surface of G0~, may provide a 
GDP-dependent binding site for Gil T. This '~2' helix is com- 
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prised between two flexible loops in the so called 'switch II' 
domain and it undergoes a dramatic onformational change 
between the GDP- and GTP-bound states: in the inactive GDP- 
bound state, the side chains of R204, W207 and F211 are 
exposed to the solvent (and may contact other proteins) 
whereas in the active GTP),S conformation they make tight 
contacts with another helical segment 'c~3' of the same protein 
domain [23]. 
We noticed that the sequence of ARF1 'switch II' domain is 
highly homologous to that of Gt0~, particularly in the '~2' helix, 
which has conserved the critical RxxWxxxF sequence (Fig. 5). 
By contrast this sequence is not conserved in Ras whose switch 
II domain has no significant homology with Gt~. This might 
be correlated to our observation that ARF~D P and GtC~GDP, but 
not rascDp, bind to Gtfly. We therefore suggest that ARF~Dp 
interacts with Gtfly, through its '~2' helix, as does Gt~GD p. This 
would account for the inhibitory competition ofGffGDP against 
ARFcDp binding, the higher affinity of Gt0~GDP for Gtfly being 
due to the existence on the N-terminal helix of Gt~ of the 
coiled-coil interaction site with Gtfl7 [21]. 
We further suggest that the 'c~2' helix of Gt0~, and the homol- 
ogous one in ARF, might be conformational analogs of the C 
terminal helix of PH (Plekstrin Homology) domains [25,26], 
which include the critical sequence RxxWxxxI. PH domains 
have been identified in many signalling proteins, some of which 
bind Gfl7 [27], possibly through their C-terminal section [28]. 
As shown on Fig. 5, homologies and analogies between the C 
terminal helix of some bona fide PH domains and the c~2 helix 
of ARF, or of Gt~, extend much beyond three conserved resi- 
dues and are indeed stronger than homologies between two PH 
domains C-terminal helix or between two G-proteins '~2' helix. 
We thus suggest more generally that the GDP-dependent GilT- 
binding motif of the '~2' helix of G proteins c~ subunit is con- 
served in the C-terminal helix of some 'PH' domains, and could 
be responsible for the binding of these PH domains to GilT. 
The physiological significance ofthe interaction ofARF with 
Gilt  remains uncertain as the affinity is low, but this interaction 
might be involved in the recently reported effect of aluminium- 
fluoride on ARFl-dependent (and probably GflT/-dependent) 
processes in Golgi membranes [29]. 
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